Exploring the paradoxical reality of TB reactivation during biologic therapy and the diagnostic challenges of false-negative test results.
Exploring the clinical characteristics and recurrence risks of EBV infection in IBD patients undergoing biologic therapy, featuring AI diagnostics and risk factors.